Abstract
The role of bioelectrical impedance (BI) analysis in determining slow-release theophylline dosage was evaluated in fifteen healthy subjects given a standard 200 mg dose. Reactance and l/resistance were identified as the most significant predictors of pre-dose, steady-state theophylline concentrations (Css,pre). Compared with doses based on body weight (8.8 mg kg-1 day-1), theophylline doses determined by BI analysis (9.6 +/- 2.4 mg kg-1 day-1) resulted in less biased (mean prediction error = 0.6 vs 1.4) though slightly less precise (mean squared error = 7.1 vs 6.3) Css,pre values. These differences were statistically insignificant (P > 0.05).
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boel J., Andersen L. B., Rasmussen B., Hansen S. H., Døssing M. Hepatic drug metabolism and physical fitness. Clin Pharmacol Ther. 1984 Jul;36(1):121–126. doi: 10.1038/clpt.1984.149. [DOI] [PubMed] [Google Scholar]
- Gikalov I., Bircher J. Dose dependence of the 14C-aminopyrine breath test. Intrasubject comparison of tracer and pharmacological doses. Eur J Clin Pharmacol. 1977 Nov 14;12(3):229–233. doi: 10.1007/BF00609866. [DOI] [PubMed] [Google Scholar]
- Hendeles L., Iafrate R. P., Weinberger M. A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products. Clin Pharmacokinet. 1984 Mar-Apr;9(2):95–135. doi: 10.2165/00003088-198409020-00001. [DOI] [PubMed] [Google Scholar]
- Kushner R. F., Schoeller D. A. Estimation of total body water by bioelectrical impedance analysis. Am J Clin Nutr. 1986 Sep;44(3):417–424. doi: 10.1093/ajcn/44.3.417. [DOI] [PubMed] [Google Scholar]
- Lukaski H. C. Applications of bioelectrical impedance analysis: a critical review. Basic Life Sci. 1990;55:365–374. doi: 10.1007/978-1-4613-1473-8_51. [DOI] [PubMed] [Google Scholar]
- Lukaski H. C., Bolonchuk W. W., Hall C. B., Siders W. A. Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol (1985) 1986 Apr;60(4):1327–1332. doi: 10.1152/jappl.1986.60.4.1327. [DOI] [PubMed] [Google Scholar]
- Lukaski H. C., Johnson P. E., Bolonchuk W. W., Lykken G. I. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 1985 Apr;41(4):810–817. doi: 10.1093/ajcn/41.4.810. [DOI] [PubMed] [Google Scholar]
- Malina R. M. Bioelectric methods for estimating body composition: an overview and discussion. Hum Biol. 1987 Apr;59(2):329–335. [PubMed] [Google Scholar]
- Miksic J. R., Hodes B. Eliminating 1,7-dimethylxanthine interference from reversed-phase liquid-chromatographic analysis for theophylline. Clin Chem. 1979 Oct;25(10):1866–1867. [PubMed] [Google Scholar]
- Pilla A. M., Zarowitz B. J., Svensson C. K., Peterson E. L., Popovich J., Jr Bioimpedance assessment of antipyrine pharmacokinetics before and after enzyme induction. DICP. 1990 Jun;24(6):575–580. doi: 10.1177/106002809002400602. [DOI] [PubMed] [Google Scholar]
- Sheiner L. B., Beal S. L. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm. 1981 Aug;9(4):503–512. doi: 10.1007/BF01060893. [DOI] [PubMed] [Google Scholar]
- Zarowitz B. J., Peterson E., Popovich J., Jr Relationship of bioelectrical impedance to pharmacokinetic parameters of theophylline in healthy males. Clin Pharmacokinet. 1989 Sep;17(3):200–207. doi: 10.2165/00003088-198917030-00005. [DOI] [PubMed] [Google Scholar]
- Zarowitz B. J., Pilla A. M. Bioelectrical impedance in clinical practice. DICP. 1989 Jul-Aug;23(7-8):548–555. doi: 10.1177/1060028089023007-803. [DOI] [PubMed] [Google Scholar]